Ascentage Pharma Group International (AAPG) Retained Earnings (2023 - 2025)
Ascentage Pharma Group International (AAPG) has disclosed Retained Earnings for 3 consecutive years, with -$988.8 million as the latest value for Q4 2025.
- For Q4 2025, Retained Earnings fell 23.09% year-over-year to -$988.8 million; the TTM value through Dec 2025 reached -$988.8 million, down 23.09%, while the annual FY2025 figure was -$1.0 billion, 26.86% down from the prior year.
- Retained Earnings hit -$988.8 million in Q4 2025 for Ascentage Pharma Group International, down from -$803.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$745.1 million in Q4 2023 and bottomed at -$988.8 million in Q4 2025.
- Average Retained Earnings over 3 years is -$845.8 million, with a median of -$803.4 million recorded in 2024.
- Year-over-year, Retained Earnings dropped 7.81% in 2024 and then dropped 23.09% in 2025.
- Ascentage Pharma Group International's Retained Earnings stood at -$745.1 million in 2023, then dropped by 7.81% to -$803.4 million in 2024, then decreased by 23.09% to -$988.8 million in 2025.
- According to Business Quant data, Retained Earnings over the past three periods came in at -$988.8 million, -$803.4 million, and -$745.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.